Users Stopping Slimming Injections Put On Weight Far More Rapidly Compared to People Using Diet and Exercise

Fresh analysis reveals that patients who discontinue popular slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass far faster than those who stop traditional diet and exercise programs.

Published data in a prominent medical journal demonstrates that while overweight individuals frequently drop a large proportion of their total mass while on the medication, the weight is regained at an average rate of 0.8 kg per month upon discontinuation.

"Users buying these treatments need to be cognizant of the potential of quick rebound weight gain when the medication concludes," stated lead investigator Dr. Susan Jebb.

This pace of regain suggests a return to original weight within about one and a half years.

Comparing Therapies

The research, which looked at 37 of studies involving thousands of patients, contrasted the outcomes of GLP-1 agonists with other pills.

Scientists emphasize that individuals who lose weight through lifestyle changes alone generally experience a slower weight regain—approximately 100 grams monthly—post-intervention.

Understanding the Fast Regain

Doctors suggest the way of the injections is key to understanding the heightened weight return.

The injections imitate a natural hormone called GLP-1, which controls feelings of fullness.

"Artificially providing GLP-1 concentrations far above than normal could lead to the body to produce less of its endogenous GLP-1, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition expert.

"Withdrawal of this hormone supplement leads to hunger is no longer kept in check, making excessive eating far more likely."

A Chronic Condition?

The NHS suggest the injections for individuals with obesity-related medical conditions, alongside recommended diet and exercise modifications.

Professionals contend that, considering the significant potential of weight regain, the therapy is often life-long.

This view is supported by pharmaceutical companies, who state that the results "emphasize the long-term nature of excess weight," comparing it to managing diseases like hypertension.

User Testimonies

People who have stopped the jabs explain a powerful return of appetite.

"It was like a trigger activating and you become ravenous," recalled one woman.

This difficulty is worsened if patients have not established lasting dietary or behavioural changes during therapy.

Widespread Use

Recent estimates indicate that a significant number of adults in the UK have used these injections in the past year, with demand continuing to grow.

• Adoption is greater among females compared to males.
• The 40s and 50s demographic shows the greatest usage rates.
• A large proportion obtain the medications through private prescriptions rather than the NHS.

Ultimately, researchers stress that while GLP-1 drugs are powerful agents for shedding pounds, they are not a magic solution and maintained weight loss relies on combined behavioural management.